Impact of peritoneal reconfiguration on lymphocele formation after robot-assisted radical prostatectomy with pelvic lymph node dissection: a systematic review and meta-analysis of randomized controlled trials

Background Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associa...

Full description

Saved in:
Bibliographic Details
Published inProstate cancer and prostatic diseases Vol. 27; no. 4; pp. 635 - 644
Main Authors Ditonno, Francesco, Manfredi, Celeste, Franco, Antonio, Veccia, Alessandro, Moro, Fabrizio Dal, De Nunzio, Cosimo, De Sio, Marco, Antonelli, Alessandro, Autorino, Riccardo
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.12.2024
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND. Methods A comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis. Results Eleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27–1.37, I 2  = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI −0.41–0.84, I 2  = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04–0.67, I 2  = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21–1.0, I 2  = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29–1.67, I 2  = 0%) were significantly lower after PF. Conclusions PF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events.
AbstractList Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND.BACKGROUNDDifferent strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND.A comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis.METHODSA comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis.Eleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27-1.37, I2 = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI -0.41-0.84, I2 = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04-0.67, I2 = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21-1.0, I2 = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29-1.67, I2 = 0%) were significantly lower after PF.RESULTSEleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27-1.37, I2 = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI -0.41-0.84, I2 = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04-0.67, I2 = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21-1.0, I2 = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29-1.67, I2 = 0%) were significantly lower after PF.PF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events.CONCLUSIONSPF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events.
BackgroundDifferent strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND.MethodsA comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis.ResultsEleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27–1.37, I2 = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI −0.41–0.84, I2 = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04–0.67, I2 = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21–1.0, I2 = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29–1.67, I2 = 0%) were significantly lower after PF.ConclusionsPF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events.
Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND. A comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis. Eleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27-1.37, I  = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI -0.41-0.84, I  = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04-0.67, I  = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21-1.0, I  = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29-1.67, I  = 0%) were significantly lower after PF. PF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events.
Background Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND). According to several recently published randomized control trials (RCTs) on the topic, peritoneal reconfiguration appears to be associated with promising results. This systematic review aimed to assess the impact of peritoneal reconfiguration on LC formation in patients undergoing RARP and PLND. Methods A comprehensive bibliographic search was conducted in August 2023. Studies assessing patients with prostate cancer undergoing RARP with PLND (P) and concomitant peritoneal reconfiguration (I) compared or not with other techniques (C) to prevent LC formation (O) were included. Original prospective and retrospective studies (S) were selected. LC and symptomatic LC rates were chosen as co-primary outcomes. Only RCTs were included in the meta-analysis. Results Eleven studies investigating 2991 patients were included in the systematic review, and five RCTs evaluating 1712 subjects were deemed eligible for meta-analysis. Peritoneal flap (PF) was the most common surgical technique used for LC prevention (9 studies). A significantly lower likelihood of LC was observed after PF (OR 0.82, 95% CI 0.27–1.37, I 2  = 74.54%), with no significant difference in terms of symptomatic LC (OR 0.21, 95% CI −0.41–0.84, I 2  = 0%). Probability of LC-related complications (OR 0.36, 95% CI 0.04–0.67, I 2  = 0%), Clavien-Dindo ≥ 3 overall complications (OR 0.61, 95% CI 0.21–1.0, I 2  = 0%), and Clavien-Dindo ≥ 3 LC-related complications (OR 0.98, 95% CI 0.29–1.67, I 2  = 0%) were significantly lower after PF. Conclusions PF after RARP with PLND reduces LC formation, LC-related complications, and severe postoperative adverse events.
Author Veccia, Alessandro
Franco, Antonio
Ditonno, Francesco
Antonelli, Alessandro
Moro, Fabrizio Dal
De Sio, Marco
Autorino, Riccardo
Manfredi, Celeste
De Nunzio, Cosimo
Author_xml – sequence: 1
  givenname: Francesco
  orcidid: 0009-0005-0126-4731
  surname: Ditonno
  fullname: Ditonno, Francesco
  organization: Department of Urology, Rush University Medical Center, Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata
– sequence: 2
  givenname: Celeste
  orcidid: 0000-0002-9706-8516
  surname: Manfredi
  fullname: Manfredi, Celeste
  organization: Department of Urology, Rush University Medical Center, Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”
– sequence: 3
  givenname: Antonio
  surname: Franco
  fullname: Franco, Antonio
  organization: Department of Urology, Rush University Medical Center, Department of Urology, Sant’Andrea Hospital, Sapienza University
– sequence: 4
  givenname: Alessandro
  orcidid: 0000-0001-5947-3206
  surname: Veccia
  fullname: Veccia, Alessandro
  organization: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata
– sequence: 5
  givenname: Fabrizio Dal
  surname: Moro
  fullname: Moro, Fabrizio Dal
  organization: Department of Surgery, Oncology, and Gastroenterology, Urology Clinic, University of Padua
– sequence: 6
  givenname: Cosimo
  orcidid: 0000-0002-2190-512X
  surname: De Nunzio
  fullname: De Nunzio, Cosimo
  organization: Department of Urology, Sant’Andrea Hospital, Sapienza University
– sequence: 7
  givenname: Marco
  surname: De Sio
  fullname: De Sio, Marco
  organization: Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”
– sequence: 8
  givenname: Alessandro
  orcidid: 0000-0002-7455-8803
  surname: Antonelli
  fullname: Antonelli, Alessandro
  organization: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata
– sequence: 9
  givenname: Riccardo
  orcidid: 0000-0001-7045-7725
  surname: Autorino
  fullname: Autorino, Riccardo
  email: ricautor@gmail.com
  organization: Department of Urology, Rush University Medical Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37875644$$D View this record in MEDLINE/PubMed
BookMark eNp9UstqFjEUHqRiL_oCLiTgxs1orpOMOym2FgpudB0ymaRNyUzGJNPy9yl9JM_faRG6KAROOHyXcztuDuY0u6Z5T_Bngpn6UjhhPWkxZS3GkvNWvGqOCJddKzqsDuDPOtFKJehhc1zKDca4Jz1-0xwyqaToOD9q_l5Mi7EVJY8Wl0MFBxNRdjbNPlyt2dSQZgQv7qblOlkXHfIpT1ve-OoyymlItTWlhFLdiLIZgwWRJadSTXW2pmmH7kK9Bot4G-ymheY0OjSGUgABYl-RQWUHCnttCyXcBneHzDyiyVXTmtnEHTjsK82QTVO4BzOos-YUI3xrDiaWt81rD8G9e4wnze-z779Of7SXP88vTr9dtpZJUVvJsZcUU8e8GJTsOBsxtlRw4QbR2YFRz_HA5ICJIML0UvVOdYQKSngvPGUnzadNF9r8s7pS9RQKjCea2aW1aKoUkYQoQQD68Rn0Jq0Z-imageLeXUpAfXhErcPkRr3kMJm800-7AoDaABYGW7Lz2ob6sIeaTYiaYL0_C72dhYaz0A9noQVQ6TPqk_qLJLaRCoDnK5f_l_0C6x_ycM60
CitedBy_id crossref_primary_10_1016_j_urology_2024_04_051
crossref_primary_10_3390_cancers16101932
crossref_primary_10_3390_cancers16112137
crossref_primary_10_1016_j_euros_2024_07_110
crossref_primary_10_1016_j_eururo_2024_09_023
crossref_primary_10_7759_cureus_77980
Cites_doi 10.1016/j.urology.2015.02.034
10.56434/j.arch.esp.urol.20227505.65
10.1016/j.urology.2022.12.002
10.23736/S2724-6051.22.05160-6
10.1089/end.2019.0716
10.1038/s41391-023-00678-y
10.1016/j.urology.2009.03.011
10.1111/bju.13425
10.1186/1471-2288-14-135
10.1111/j.1464-410X.2011.10094.x
10.1016/j.eururo.2022.07.027
10.4103/iju.IJU_284_18
10.1016/j.euo.2023.07.009
10.1111/j.1464-410X.2012.11681.x
10.1016/j.urology.2017.05.031
10.1016/j.eururo.2006.08.015
10.1136/bmj.n71
10.1016/j.eururo.2016.08.006
10.1007/s11701-019-01010-4
10.1186/1471-2288-8-56
10.1111/bju.15497
10.1097/01.sla.0000133083.54934.ae
10.1111/biom.12817
10.1089/end.2020.0073
10.1097/JU.0000000000002693
10.1186/s13643-017-0644-y
10.1097/JU.0000000000002758
10.1038/s41391-022-00565-y
10.1002/sim.1186
10.3390/jcm12030791
10.5152/tud.2020.20255
10.1007/s00345-008-0327-3
10.1038/s41391-022-00635-1
10.1089/end.2010.0635
10.1136/emermed-2020-209567
10.1136/bmj.l4898
10.1111/j.1464-410X.2010.09580.x
10.1016/j.euf.2021.06.010
10.1016/j.euf.2023.07.007
10.1136/bmj.i4919
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Nature Limited 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. The Author(s), under exclusive licence to Springer Nature Limited.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Nature Limited 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. The Author(s), under exclusive licence to Springer Nature Limited.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TO
8FD
FR3
H94
K9.
M7Z
P64
7X8
DOI 10.1038/s41391-023-00744-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biochemistry Abstracts 1
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Oncogenes and Growth Factors Abstracts
Technology Research Database
Biochemistry Abstracts 1
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Oncogenes and Growth Factors Abstracts
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1476-5608
EndPage 644
ExternalDocumentID 37875644
10_1038_s41391_023_00744_5
Genre Meta-Analysis
Systematic Review
Journal Article
GroupedDBID ---
-Q-
0R~
123
29P
2WC
36B
39C
4.4
406
53G
70F
7X7
88E
8AO
8C1
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAYZH
ABAKF
ABAWZ
ABBRH
ABDBE
ABDBF
ABFSG
ABJNI
ABRTQ
ABUWG
ABZZP
ACAOD
ACGFS
ACIWK
ACKTT
ACPRK
ACRQY
ACSTC
ACUHS
ACZOJ
ADBBV
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ATHPR
AXYYD
AYFIA
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
DU5
E3Z
EAD
EAP
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
FDQFY
FERAY
FIGPU
FIZPM
FYUFA
HCIFZ
HMCUK
HZ~
IAO
IHR
IHW
INH
INR
ITC
IWAJR
JSO
JZLTJ
KQ8
M1P
M7P
NQJWS
O9-
OK1
OVD
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RNS
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UDS
UKHRP
~8M
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TO
8FD
FR3
H94
K9.
M7Z
P64
7X8
ID FETCH-LOGICAL-c375t-740f7202e3f5b87643d00c2545eb56cb32f40b37b01515a9789e8612521495f23
ISSN 1365-7852
1476-5608
IngestDate Mon Aug 25 04:31:31 EDT 2025
Sat Aug 23 12:54:32 EDT 2025
Mon Jul 21 06:04:31 EDT 2025
Tue Jul 01 03:42:16 EDT 2025
Thu Apr 24 23:10:00 EDT 2025
Mon Jul 21 06:07:58 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License 2023. The Author(s), under exclusive licence to Springer Nature Limited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c375t-740f7202e3f5b87643d00c2545eb56cb32f40b37b01515a9789e8612521495f23
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Undefined-1
ObjectType-Review-4
content type line 23
ORCID 0000-0002-7455-8803
0009-0005-0126-4731
0000-0002-9706-8516
0000-0002-2190-512X
0000-0001-5947-3206
0000-0001-7045-7725
PMID 37875644
PQID 3125876477
PQPubID 27992
PageCount 10
ParticipantIDs proquest_miscellaneous_2881711851
proquest_journals_3125876477
pubmed_primary_37875644
crossref_citationtrail_10_1038_s41391_023_00744_5
crossref_primary_10_1038_s41391_023_00744_5
springer_journals_10_1038_s41391_023_00744_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-12-01
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-12-01
  day: 01
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: Houndmills
PublicationTitle Prostate cancer and prostatic diseases
PublicationTitleAbbrev Prostate Cancer Prostatic Dis
PublicationTitleAlternate Prostate Cancer Prostatic Dis
PublicationYear 2024
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References MotterleGMorlaccoAZanovelloNAhmedMEZattoniFKarnesRJSurgical Strategies for Lymphocele Prevention in Minimally Invasive Radical Prostatectomy and Lymph Node Dissection: A Systematic ReviewJ Endourol2020341132010.1089/end.2019.071631797684
Dal MoroFZattoniFP.L.E.A.T.—Preventing Lymphocele Ensuring Absorption Transperitoneally: A Robotic TechniqueUrology2017110244710.1016/j.urology.2017.05.03128554519
KeskinMSArgunÖBÖbekCTufekITunaMBMourmourisPThe incidence and sequela of lymphocele formation after robot-assisted extended pelvic lymph node dissectionBJU Int20161181273110.1111/bju.1342526800257
BasourakosSPZhuALewickiPJRamaswamyAChengEDudleyVClipless Robotic-assisted Radical Prostatectomy and Impact on OutcomesEur Urol Focus2022811768510.1016/j.euf.2021.06.01034246618
EasthamJAAuffenbergGBBarocasDAChouRCrispinoTDavisJWClinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-UpJ Urol2022208192510.1097/JU.000000000000275835536148
Creta M, Manfredi C, Arcaniolo D, Spirito L, Kaplan SA, Woo HH, et al. Functional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysis. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-023-00678-y
BoğaMSSönmezMGKaramikKYilmazKSavaşMAteşMThe effect of peritoneal re-approximation on lymphocele formation in transperitoneal robot-assisted radical prostatectomy and extended pelvic lymphadenectomyTurk J Urol202046460710.5152/tud.2020.20255328336187608535
MaJLiuWHunterAZhangWPerforming meta-analysis with incomplete statistical information in clinical trialsBMC Med Res Methodol2008810.1186/1471-2288-8-56187061242571096
DanuserHDi PierroGBStuckiPMatteiAExtended pelvic lymphadenectomy and various radical prostatectomy techniques: Is pelvic drainage necessary?BJU Int2013111963910.1111/j.1464-410X.2012.11681.x23356829
May M, Gilfrich C, Bründl J, Ubrig B, Wagner JR, Gloger S, et al. Impact of Peritoneal Interposition Flap on Patients Undergoing Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Focus. 2023. https://doi.org/10.1016/j.euf.2023.07.007 S2405-456900181-5.
Neuberger M, Kowalewski K, Simon V, von Hardenberg J, Siegel F, Wessels F, et al. Peritoneal Flap for Lymphocele Prophylaxis Following Robotic-assisted Radical Prostatectomy with Lymph Node Dissection: The Randomised Controlled Phase 3 PELYCAN Trial. Eur Urol Oncol. 2023; https://doi.org/10.1016/j.euo.2023.07.009 S2588-931100152-9.
StolzenburgJUWasserscheidJRabenaltRDoMSchwalenbergTMcNeillAReduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestrationWorld J Urol200826581610.1007/s00345-008-0327-318777125
DindoDDemartinesNClavienPAClassification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a surveyAnn Surg20042402051310.1097/01.sla.0000133083.54934.ae152735421360123
OrvietoMACoelhoRFChauhanSPalmerKJRoccoBPatelVRIncidence of lymphoceles after robot-assisted pelvic lymph node dissectionBJU Int201110811859010.1111/j.1464-410X.2011.10094.x21489117
Seetharam BhatKROnolFRogersTGanapathiHPMoschovasMRoofSCan we predict who will need lymphocele drainage following robot assisted laparoscopic prostatectomy (RALP)?J Robot Surg202014439451:STN:280:DC%2BB3MvovFKruw%3D%3D10.1007/s11701-019-01010-431422556
Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberatiet A, al. The Oxford 2011 Levels of Evidence. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence. Last access: August 12, 2023.
LebeisCCanesDSorciniAMoinzadehANovel technique prevents lymphoceles after transperitoneal robotic-assisted pelvic lymph node dissection: Peritoneal flap interpositionUrology2015851505910.1016/j.urology.2015.02.03426099895
PoseRMKnipperSWürnschimmelCTennstedtPMichlUMaurerTSignificant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissectionBJU Int20211287283310.1111/bju.1549734036733
LinLChuHQuantifying publication bias in meta-analysisBiometrics2018747859410.1111/biom.1281729141096
KallappanSManickamRNachimuthuSGanesapandiTUnusual lymphocele following radical cystectomy with orthotopic neobladderIndian J Urol201935168910.4103/iju.IJU_284_18310009266458803
Masterson J, Luu M, Naser-Tavakolian A, Freedland S, Sandler H, Zumsteg Z, et al. Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-022-00635-1
BrigantiAChunFKHSaloniaASuardiNGallinaADa PozzoLFComplications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate CancerEur Urol20065010061310.1016/j.eururo.2006.08.01516959399
BramerWMRethlefsenMLKleijnenJFrancoOHOptimal database combinations for literature searches in systematic reviews: A prospective exploratory studySyst Rev2017610.1186/s13643-017-0644-y292080345718002
SterneJACSavovićJPageMJElbersRGBlencoweNSBoutronIRoB 2: A revised tool for assessing risk of bias in randomised trialsBMJ2019366l489810.1136/bmj.l489831462531
HarlandNAlfarraMErneEMaasMAmendBBedkeJA Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical ProstatectomyJ Clin Med20231279110.3390/jcm12030791367694409917373
HigginsJPTThompsonSGQuantifying heterogeneity in a meta-analysisStat Med20022115395810.1002/sim.118612111919
WanXWangWLiuJTongTEstimating the sample mean and standard deviation from the sample size, median, range and/or interquartile rangeBMC Med Res Methodol20141410.1186/1471-2288-14-135255244434383202
LeeMLeeZEunDDUtilization of a Peritoneal Interposition Flap to Prevent Symptomatic Lymphoceles after Robotic Radical Prostatectomy and Bilateral Pelvic Lymph Node DissectionJ Endourol202034821710.1089/end.2020.007332303137
GlogerSUbrigBBoyALeyh-BannurahSRSiemerSArndtMBilateral Peritoneal Flaps Reduce Incidence and Complications of Lymphoceles after Robotic Radical Prostatectomy with Pelvic Lymph Node Dissection - Results of the Prospective Randomized Multicenter Trial ProLyJ Urol20222083334010.1097/JU.0000000000002693354221369275839
CapitanioUPellucchiFGallinaABrigantiASuardiNSaloniaAHow can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implicationsBJU Int2011107109510110.1111/j.1464-410X.2010.09580.x20880192
GrandePDi PierroGBMordasiniLFerrariMWürnschimmelCDanuserHProspective Randomized Trial Comparing Titanium Clips to Bipolar Coagulation in Sealing Lymphatic Vessels During Pelvic Lymph Node Dissection at the Time of Robot-assisted Radical ProstatectomyEur Urol201771155810.1016/j.eururo.2016.08.00627544575
Amir-BehghadamiMJanatiAPopulation, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviewsEmerg Med J20203738710.1136/emermed-2020-20956732253195
Mottet N, Cornford P, Van den Bergh R, Eberli D, De Meerleer G, De Santis M, et al. EAU Guidelines on Prostate Cancer. Edn presented at the EAU Annual Congress Milan. 2023. ISBN 978-94-92671-19-6
FioriCCheccucciESturaIAmparoreDDe CillisSPianaADevelopment of a novel nomogram to identify the candidate to extended pelvic lymph node dissection in patients who underwent mpMRI and target biopsy onlyProstate Cancer Prostatic Dis2023263889410.1038/s41391-022-00565-y35750851
StudentVTudosZStudentovaZCesakOStudentovaHRepaVEffect of Peritoneal Fixation (PerFix) on Lymphocele Formation in Robot-assisted Radical Prostatectomy with Pelvic Lymphadenectomy: Results of a Randomized Prospective TrialEur Urol2023831546210.1016/j.eururo.2022.07.02736041934
WagnerJMcLaughlinTPintoKTortoraJGangakhedkarAStaffIThe Effect of a Peritoneal Iliac Flap on Lymphocele Formation After Robotic Radical Prostatectomy: Results From the PLUS TrialUrology20231731041010.1016/j.urology.2022.12.00236549574
BründlJLenartSStojanoskiGGilfrichCRosenhammerBStolzlechnerMPeritoneal flap in robot-assisted radical prostatectomy: Results of a multicenter, randomized, single-blind study (PIANOFORTE) of the efficacy in reducing postoperative lymphoceleDtsch Arztebl Int202011724350324498967264288
PageMJMcKenzieJEBossuytPMBoutronIHoffmannTCMulrowCDThe PRISMA 2020 statement: An updated guideline for reporting systematic reviewsBMJ2021372n7110.1136/bmj.n71337820578005924
YılmazKÖlçücüMTArıÖKaramikKAktaşYSavaşMThe Results of Peritoneal Re-Approximation Methods on Symptomatic Lymphocele Formation in Robot-Assisted Laparoscopic Radical Prostatectomy and Extended Pelvic LymphadenectomyArch Esp Urol2022754475210.56434/j.arch.esp.urol.20227505.6535983817
SterneJAHernánMAReevesBCSavovićJBerkmanNDViswanathanMROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventionsBMJ2016355i491910.1136/bmj.i4919277333545062054
WaldertMRemziMKlatteTKlinglerHCFloseal reduces the incidence of lymphoceles after lymphadenectomies in laparoscopic and robot-assisted extraperitoneal radical prostatectomyJ Endourol2011259697310.1089/end.2010.063521542773
NaselliAAndreattaRIntroiniCFontanaVPuppoPPredictors of Symptomatic Lymphocele After Lymph Node Excision and Radical ProstatectomyUrology201075630510.1016/j.urology.2009.03.01119476977
TerritoABaboudjianMDianaPGallioliAVerriPUleriATo drain or not to drain in uro-oncological robotic surgery? A systematic review and meta-analysisMinerva Urol Nephrol2023751445310.23736/S2724-6051.22.05160-636722161
P Grande (744_CR13) 2017; 71
M Amir-Behghadami (744_CR20) 2020; 37
744_CR25
N Harland (744_CR31) 2023; 12
M Lee (744_CR34) 2020; 34
A Naselli (744_CR11) 2010; 75
J Bründl (744_CR17) 2020; 117
MS Keskin (744_CR8) 2016; 118
D Dindo (744_CR22) 2004; 240
M Waldert (744_CR12) 2011; 25
S Gloger (744_CR32) 2022; 208
JA Eastham (744_CR2) 2022; 208
JPT Higgins (744_CR28) 2002; 21
MJ Page (744_CR18) 2021; 372
RM Pose (744_CR36) 2021; 128
744_CR43
X Wan (744_CR26) 2014; 14
J Wagner (744_CR30) 2023; 173
KR Seetharam Bhat (744_CR42) 2020; 14
C Fiori (744_CR3) 2023; 26
V Student (744_CR15) 2023; 83
JA Sterne (744_CR24) 2016; 355
MA Orvieto (744_CR7) 2011; 108
J Ma (744_CR27) 2008; 8
744_CR1
C Lebeis (744_CR9) 2015; 85
744_CR5
744_CR4
G Motterle (744_CR21) 2020; 34
744_CR16
JU Stolzenburg (744_CR10) 2008; 26
MS Boğa (744_CR33) 2020; 46
F Dal Moro (744_CR35) 2017; 110
WM Bramer (744_CR19) 2017; 6
A Territo (744_CR40) 2023; 75
K Yılmaz (744_CR14) 2022; 75
S Kallappan (744_CR37) 2019; 35
H Danuser (744_CR39) 2013; 111
U Capitanio (744_CR41) 2011; 107
A Briganti (744_CR6) 2006; 50
SP Basourakos (744_CR38) 2022; 8
JAC Sterne (744_CR23) 2019; 366
L Lin (744_CR29) 2018; 74
References_xml – reference: PoseRMKnipperSWürnschimmelCTennstedtPMichlUMaurerTSignificant reduction of lymphoceles after radical prostatectomy and pelvic lymph node dissectionBJU Int20211287283310.1111/bju.1549734036733
– reference: Creta M, Manfredi C, Arcaniolo D, Spirito L, Kaplan SA, Woo HH, et al. Functional and oncological outcomes after radical prostatectomy in patients with history of surgery for lower urinary tract symptoms related to benign prostatic enlargement: A systematic review with meta-analysis. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-023-00678-y
– reference: Seetharam BhatKROnolFRogersTGanapathiHPMoschovasMRoofSCan we predict who will need lymphocele drainage following robot assisted laparoscopic prostatectomy (RALP)?J Robot Surg202014439451:STN:280:DC%2BB3MvovFKruw%3D%3D10.1007/s11701-019-01010-431422556
– reference: WagnerJMcLaughlinTPintoKTortoraJGangakhedkarAStaffIThe Effect of a Peritoneal Iliac Flap on Lymphocele Formation After Robotic Radical Prostatectomy: Results From the PLUS TrialUrology20231731041010.1016/j.urology.2022.12.00236549574
– reference: CapitanioUPellucchiFGallinaABrigantiASuardiNSaloniaAHow can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implicationsBJU Int2011107109510110.1111/j.1464-410X.2010.09580.x20880192
– reference: MaJLiuWHunterAZhangWPerforming meta-analysis with incomplete statistical information in clinical trialsBMC Med Res Methodol2008810.1186/1471-2288-8-56187061242571096
– reference: HigginsJPTThompsonSGQuantifying heterogeneity in a meta-analysisStat Med20022115395810.1002/sim.118612111919
– reference: SterneJACSavovićJPageMJElbersRGBlencoweNSBoutronIRoB 2: A revised tool for assessing risk of bias in randomised trialsBMJ2019366l489810.1136/bmj.l489831462531
– reference: SterneJAHernánMAReevesBCSavovićJBerkmanNDViswanathanMROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventionsBMJ2016355i491910.1136/bmj.i4919277333545062054
– reference: KallappanSManickamRNachimuthuSGanesapandiTUnusual lymphocele following radical cystectomy with orthotopic neobladderIndian J Urol201935168910.4103/iju.IJU_284_18310009266458803
– reference: EasthamJAAuffenbergGBBarocasDAChouRCrispinoTDavisJWClinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-UpJ Urol2022208192510.1097/JU.000000000000275835536148
– reference: LebeisCCanesDSorciniAMoinzadehANovel technique prevents lymphoceles after transperitoneal robotic-assisted pelvic lymph node dissection: Peritoneal flap interpositionUrology2015851505910.1016/j.urology.2015.02.03426099895
– reference: WanXWangWLiuJTongTEstimating the sample mean and standard deviation from the sample size, median, range and/or interquartile rangeBMC Med Res Methodol20141410.1186/1471-2288-14-135255244434383202
– reference: WaldertMRemziMKlatteTKlinglerHCFloseal reduces the incidence of lymphoceles after lymphadenectomies in laparoscopic and robot-assisted extraperitoneal radical prostatectomyJ Endourol2011259697310.1089/end.2010.063521542773
– reference: PageMJMcKenzieJEBossuytPMBoutronIHoffmannTCMulrowCDThe PRISMA 2020 statement: An updated guideline for reporting systematic reviewsBMJ2021372n7110.1136/bmj.n71337820578005924
– reference: BasourakosSPZhuALewickiPJRamaswamyAChengEDudleyVClipless Robotic-assisted Radical Prostatectomy and Impact on OutcomesEur Urol Focus2022811768510.1016/j.euf.2021.06.01034246618
– reference: TerritoABaboudjianMDianaPGallioliAVerriPUleriATo drain or not to drain in uro-oncological robotic surgery? A systematic review and meta-analysisMinerva Urol Nephrol2023751445310.23736/S2724-6051.22.05160-636722161
– reference: Mottet N, Cornford P, Van den Bergh R, Eberli D, De Meerleer G, De Santis M, et al. EAU Guidelines on Prostate Cancer. Edn presented at the EAU Annual Congress Milan. 2023. ISBN 978-94-92671-19-6
– reference: MotterleGMorlaccoAZanovelloNAhmedMEZattoniFKarnesRJSurgical Strategies for Lymphocele Prevention in Minimally Invasive Radical Prostatectomy and Lymph Node Dissection: A Systematic ReviewJ Endourol2020341132010.1089/end.2019.071631797684
– reference: DindoDDemartinesNClavienPAClassification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a surveyAnn Surg20042402051310.1097/01.sla.0000133083.54934.ae152735421360123
– reference: Dal MoroFZattoniFP.L.E.A.T.—Preventing Lymphocele Ensuring Absorption Transperitoneally: A Robotic TechniqueUrology2017110244710.1016/j.urology.2017.05.03128554519
– reference: BründlJLenartSStojanoskiGGilfrichCRosenhammerBStolzlechnerMPeritoneal flap in robot-assisted radical prostatectomy: Results of a multicenter, randomized, single-blind study (PIANOFORTE) of the efficacy in reducing postoperative lymphoceleDtsch Arztebl Int202011724350324498967264288
– reference: Masterson J, Luu M, Naser-Tavakolian A, Freedland S, Sandler H, Zumsteg Z, et al. Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer. Prostate Cancer Prostatic Dis. 2023. https://doi.org/10.1038/s41391-022-00635-1
– reference: NaselliAAndreattaRIntroiniCFontanaVPuppoPPredictors of Symptomatic Lymphocele After Lymph Node Excision and Radical ProstatectomyUrology201075630510.1016/j.urology.2009.03.01119476977
– reference: BrigantiAChunFKHSaloniaASuardiNGallinaADa PozzoLFComplications and Other Surgical Outcomes Associated with Extended Pelvic Lymphadenectomy in Men with Localized Prostate CancerEur Urol20065010061310.1016/j.eururo.2006.08.01516959399
– reference: KeskinMSArgunÖBÖbekCTufekITunaMBMourmourisPThe incidence and sequela of lymphocele formation after robot-assisted extended pelvic lymph node dissectionBJU Int20161181273110.1111/bju.1342526800257
– reference: StudentVTudosZStudentovaZCesakOStudentovaHRepaVEffect of Peritoneal Fixation (PerFix) on Lymphocele Formation in Robot-assisted Radical Prostatectomy with Pelvic Lymphadenectomy: Results of a Randomized Prospective TrialEur Urol2023831546210.1016/j.eururo.2022.07.02736041934
– reference: May M, Gilfrich C, Bründl J, Ubrig B, Wagner JR, Gloger S, et al. Impact of Peritoneal Interposition Flap on Patients Undergoing Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Focus. 2023. https://doi.org/10.1016/j.euf.2023.07.007 S2405-456900181-5.
– reference: StolzenburgJUWasserscheidJRabenaltRDoMSchwalenbergTMcNeillAReduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestrationWorld J Urol200826581610.1007/s00345-008-0327-318777125
– reference: YılmazKÖlçücüMTArıÖKaramikKAktaşYSavaşMThe Results of Peritoneal Re-Approximation Methods on Symptomatic Lymphocele Formation in Robot-Assisted Laparoscopic Radical Prostatectomy and Extended Pelvic LymphadenectomyArch Esp Urol2022754475210.56434/j.arch.esp.urol.20227505.6535983817
– reference: LinLChuHQuantifying publication bias in meta-analysisBiometrics2018747859410.1111/biom.1281729141096
– reference: HarlandNAlfarraMErneEMaasMAmendBBedkeJA Peritoneal Purse-String Suture Prevents Symptomatic Lymphoceles in Retzius-Sparing Robot-Assisted Radical ProstatectomyJ Clin Med20231279110.3390/jcm12030791367694409917373
– reference: BoğaMSSönmezMGKaramikKYilmazKSavaşMAteşMThe effect of peritoneal re-approximation on lymphocele formation in transperitoneal robot-assisted radical prostatectomy and extended pelvic lymphadenectomyTurk J Urol202046460710.5152/tud.2020.20255328336187608535
– reference: LeeMLeeZEunDDUtilization of a Peritoneal Interposition Flap to Prevent Symptomatic Lymphoceles after Robotic Radical Prostatectomy and Bilateral Pelvic Lymph Node DissectionJ Endourol202034821710.1089/end.2020.007332303137
– reference: Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberatiet A, al. The Oxford 2011 Levels of Evidence. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence. Last access: August 12, 2023.
– reference: FioriCCheccucciESturaIAmparoreDDe CillisSPianaADevelopment of a novel nomogram to identify the candidate to extended pelvic lymph node dissection in patients who underwent mpMRI and target biopsy onlyProstate Cancer Prostatic Dis2023263889410.1038/s41391-022-00565-y35750851
– reference: OrvietoMACoelhoRFChauhanSPalmerKJRoccoBPatelVRIncidence of lymphoceles after robot-assisted pelvic lymph node dissectionBJU Int201110811859010.1111/j.1464-410X.2011.10094.x21489117
– reference: BramerWMRethlefsenMLKleijnenJFrancoOHOptimal database combinations for literature searches in systematic reviews: A prospective exploratory studySyst Rev2017610.1186/s13643-017-0644-y292080345718002
– reference: GlogerSUbrigBBoyALeyh-BannurahSRSiemerSArndtMBilateral Peritoneal Flaps Reduce Incidence and Complications of Lymphoceles after Robotic Radical Prostatectomy with Pelvic Lymph Node Dissection - Results of the Prospective Randomized Multicenter Trial ProLyJ Urol20222083334010.1097/JU.0000000000002693354221369275839
– reference: DanuserHDi PierroGBStuckiPMatteiAExtended pelvic lymphadenectomy and various radical prostatectomy techniques: Is pelvic drainage necessary?BJU Int2013111963910.1111/j.1464-410X.2012.11681.x23356829
– reference: GrandePDi PierroGBMordasiniLFerrariMWürnschimmelCDanuserHProspective Randomized Trial Comparing Titanium Clips to Bipolar Coagulation in Sealing Lymphatic Vessels During Pelvic Lymph Node Dissection at the Time of Robot-assisted Radical ProstatectomyEur Urol201771155810.1016/j.eururo.2016.08.00627544575
– reference: Neuberger M, Kowalewski K, Simon V, von Hardenberg J, Siegel F, Wessels F, et al. Peritoneal Flap for Lymphocele Prophylaxis Following Robotic-assisted Radical Prostatectomy with Lymph Node Dissection: The Randomised Controlled Phase 3 PELYCAN Trial. Eur Urol Oncol. 2023; https://doi.org/10.1016/j.euo.2023.07.009 S2588-931100152-9.
– reference: Amir-BehghadamiMJanatiAPopulation, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviewsEmerg Med J20203738710.1136/emermed-2020-20956732253195
– volume: 85
  start-page: 1505
  year: 2015
  ident: 744_CR9
  publication-title: Urology
  doi: 10.1016/j.urology.2015.02.034
– volume: 75
  start-page: 447
  year: 2022
  ident: 744_CR14
  publication-title: Arch Esp Urol
  doi: 10.56434/j.arch.esp.urol.20227505.65
– volume: 173
  start-page: 104
  year: 2023
  ident: 744_CR30
  publication-title: Urology
  doi: 10.1016/j.urology.2022.12.002
– volume: 75
  start-page: 144
  year: 2023
  ident: 744_CR40
  publication-title: Minerva Urol Nephrol
  doi: 10.23736/S2724-6051.22.05160-6
– volume: 34
  start-page: 113
  year: 2020
  ident: 744_CR21
  publication-title: J Endourol
  doi: 10.1089/end.2019.0716
– ident: 744_CR5
  doi: 10.1038/s41391-023-00678-y
– volume: 75
  start-page: 630
  year: 2010
  ident: 744_CR11
  publication-title: Urology
  doi: 10.1016/j.urology.2009.03.011
– volume: 118
  start-page: 127
  year: 2016
  ident: 744_CR8
  publication-title: BJU Int
  doi: 10.1111/bju.13425
– volume: 14
  year: 2014
  ident: 744_CR26
  publication-title: BMC Med Res Methodol
  doi: 10.1186/1471-2288-14-135
– volume: 108
  start-page: 1185
  year: 2011
  ident: 744_CR7
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2011.10094.x
– volume: 83
  start-page: 154
  year: 2023
  ident: 744_CR15
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2022.07.027
– volume: 35
  start-page: 168
  year: 2019
  ident: 744_CR37
  publication-title: Indian J Urol
  doi: 10.4103/iju.IJU_284_18
– ident: 744_CR16
  doi: 10.1016/j.euo.2023.07.009
– volume: 117
  start-page: 243
  year: 2020
  ident: 744_CR17
  publication-title: Dtsch Arztebl Int
– volume: 111
  start-page: 963
  year: 2013
  ident: 744_CR39
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2012.11681.x
– volume: 110
  start-page: 244
  year: 2017
  ident: 744_CR35
  publication-title: Urology
  doi: 10.1016/j.urology.2017.05.031
– volume: 50
  start-page: 1006
  year: 2006
  ident: 744_CR6
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2006.08.015
– volume: 372
  start-page: n71
  year: 2021
  ident: 744_CR18
  publication-title: BMJ
  doi: 10.1136/bmj.n71
– volume: 71
  start-page: 155
  year: 2017
  ident: 744_CR13
  publication-title: Eur Urol
  doi: 10.1016/j.eururo.2016.08.006
– volume: 14
  start-page: 439
  year: 2020
  ident: 744_CR42
  publication-title: J Robot Surg
  doi: 10.1007/s11701-019-01010-4
– volume: 8
  year: 2008
  ident: 744_CR27
  publication-title: BMC Med Res Methodol
  doi: 10.1186/1471-2288-8-56
– volume: 128
  start-page: 728
  year: 2021
  ident: 744_CR36
  publication-title: BJU Int
  doi: 10.1111/bju.15497
– volume: 240
  start-page: 205
  year: 2004
  ident: 744_CR22
  publication-title: Ann Surg
  doi: 10.1097/01.sla.0000133083.54934.ae
– volume: 74
  start-page: 785
  year: 2018
  ident: 744_CR29
  publication-title: Biometrics
  doi: 10.1111/biom.12817
– ident: 744_CR25
– volume: 34
  start-page: 821
  year: 2020
  ident: 744_CR34
  publication-title: J Endourol
  doi: 10.1089/end.2020.0073
– volume: 208
  start-page: 333
  year: 2022
  ident: 744_CR32
  publication-title: J Urol
  doi: 10.1097/JU.0000000000002693
– volume: 6
  year: 2017
  ident: 744_CR19
  publication-title: Syst Rev
  doi: 10.1186/s13643-017-0644-y
– volume: 208
  start-page: 19
  year: 2022
  ident: 744_CR2
  publication-title: J Urol
  doi: 10.1097/JU.0000000000002758
– volume: 26
  start-page: 388
  year: 2023
  ident: 744_CR3
  publication-title: Prostate Cancer Prostatic Dis
  doi: 10.1038/s41391-022-00565-y
– volume: 21
  start-page: 1539
  year: 2002
  ident: 744_CR28
  publication-title: Stat Med
  doi: 10.1002/sim.1186
– volume: 12
  start-page: 791
  year: 2023
  ident: 744_CR31
  publication-title: J Clin Med
  doi: 10.3390/jcm12030791
– volume: 46
  start-page: 460
  year: 2020
  ident: 744_CR33
  publication-title: Turk J Urol
  doi: 10.5152/tud.2020.20255
– ident: 744_CR1
– volume: 26
  start-page: 581
  year: 2008
  ident: 744_CR10
  publication-title: World J Urol
  doi: 10.1007/s00345-008-0327-3
– ident: 744_CR4
  doi: 10.1038/s41391-022-00635-1
– volume: 25
  start-page: 969
  year: 2011
  ident: 744_CR12
  publication-title: J Endourol
  doi: 10.1089/end.2010.0635
– volume: 37
  start-page: 387
  year: 2020
  ident: 744_CR20
  publication-title: Emerg Med J
  doi: 10.1136/emermed-2020-209567
– volume: 366
  start-page: l4898
  year: 2019
  ident: 744_CR23
  publication-title: BMJ
  doi: 10.1136/bmj.l4898
– volume: 107
  start-page: 1095
  year: 2011
  ident: 744_CR41
  publication-title: BJU Int
  doi: 10.1111/j.1464-410X.2010.09580.x
– volume: 8
  start-page: 1176
  year: 2022
  ident: 744_CR38
  publication-title: Eur Urol Focus
  doi: 10.1016/j.euf.2021.06.010
– ident: 744_CR43
  doi: 10.1016/j.euf.2023.07.007
– volume: 355
  start-page: i4919
  year: 2016
  ident: 744_CR24
  publication-title: BMJ
  doi: 10.1136/bmj.i4919
SSID ssj0009190
Score 2.4131138
SecondaryResourceType review_article
Snippet Background Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection...
Different strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection (PLND)....
BackgroundDifferent strategies have been proposed to prevent lymphocele (LC) formation after radical prostatectomy (RARP) with pelvic lymph node dissection...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 635
SubjectTerms 692/308/409
692/699/67/1059
692/699/67/589/466
Biomedical and Life Sciences
Biomedicine
Cancer Research
Clinical outcomes
Clinical trials
Dissection
Humans
Impact analysis
Lymph Node Excision - adverse effects
Lymph Node Excision - methods
Lymph nodes
Lymphatic system
Lymphocele
Lymphocele - epidemiology
Lymphocele - etiology
Lymphocele - prevention & control
Male
Meta-analysis
Pelvis - pathology
Pelvis - surgery
Peritoneum
Peritoneum - pathology
Peritoneum - surgery
Postoperative Complications - epidemiology
Postoperative Complications - etiology
Postoperative Complications - prevention & control
Prostate cancer
Prostatectomy
Prostatectomy - adverse effects
Prostatectomy - methods
Prostatic Neoplasms - pathology
Prostatic Neoplasms - surgery
Randomized Controlled Trials as Topic
Reconfiguration
Reproductive Medicine
Review Article
Robotic surgery
Robotic Surgical Procedures - adverse effects
Robotic Surgical Procedures - methods
Side effects
Systematic review
Title Impact of peritoneal reconfiguration on lymphocele formation after robot-assisted radical prostatectomy with pelvic lymph node dissection: a systematic review and meta-analysis of randomized controlled trials
URI https://link.springer.com/article/10.1038/s41391-023-00744-5
https://www.ncbi.nlm.nih.gov/pubmed/37875644
https://www.proquest.com/docview/3125876477
https://www.proquest.com/docview/2881711851
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb5wwELbykKpeqr67bVo5Um9bp2AbDL1t2kZppUQ9JFVuyICJIrHLapc9JL-yP6njB5jNNlVTCSFkYDDMh2fGHn9G6L2SSQWeaEryhHHCKxmQPBU5YaUIeSSTIDV9uien8fE5_34RXWxt7w-yllZtflDc_HFeyf9oFcpAr3qW7D002wuFAjgG_cIeNAz7f9Lxt36Ko-Yr1rTahqYfQtzq6nLldAtbfQ06A0NVKz9Z0a0OvmjypiXgQWt1l-OFtOM2cz0ZROoBhmZ6bTtr56qGVsXKGs-aUo3NWH7RZYfIDVZom2w8Va0kcsB9AtaxbKZXN6rsEuVrODTLhyyHvvIPVwedmFaohaM0MGXwBDey1IcEX_T7m3XE7WIhalk0vrt9Vi3ASpteYfgKy7aHs7m2cTQK0L719_wE1NlE4kmtl4nRxA7DLhLKB-kmtlXXqXwisVS5B8qWcRETcPeSoSmwNAUO8nzQrseWU8W5CLGlrNywPpZrfgl-gU4no4xoB42TyNvaLr_glgnuEyNNSgBLMisjAxmZkZFF22iXQiQETfnu5Ojw8NQzS4dp0E0u1O_oZoaBlI-bNVn3vjZCqo10AONlnT1Gj1x4hCcW60_Qlpo9RQ9OXALIM_TLQh43FfaQx7cgj2HzkMc95LGBPF6HPHaQx2uQxxry2ELeysIa8thD_hOW2AMeW8BjgAleA7yuqQc89oDHFvDP0fnR17PPx8QtSkIKJqKWCB5UAkCmWBXl4EpwVgZBQSEQUXkUFzmjFQ9yJvJAhwoyFUmqEh1GUN0XUVH2Au3M4OO8QjhJqeQxlTEPC664kAVPyyCUQVmFMqV0hMJOWVnhGPv1wjF1djdMRmjc3zO3fDV_vXqvw0Dm2rVlxqCy-sWEGKH9_jRYHT2UKGeqWS0zmiShCMHXD0fopcVO_zgGPkAEv8gIfejA5IXfXZfX96r5G_TQ_-l7aKddrNRbCA_a_J37QX4DXgoWnA
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+peritoneal+reconfiguration+on+lymphocele+formation+after+robot-assisted+radical+prostatectomy+with+pelvic+lymph+node+dissection%3A+a+systematic+review+and+meta-analysis+of+randomized+controlled+trials&rft.jtitle=Prostate+cancer+and+prostatic+diseases&rft.au=Ditonno%2C+Francesco&rft.au=Manfredi%2C+Celeste&rft.au=Franco%2C+Antonio&rft.au=Veccia%2C+Alessandro&rft.date=2024-12-01&rft.issn=1365-7852&rft.eissn=1476-5608&rft.volume=27&rft.issue=4&rft.spage=635&rft.epage=644&rft_id=info:doi/10.1038%2Fs41391-023-00744-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41391_023_00744_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1365-7852&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1365-7852&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1365-7852&client=summon